{
  "id": 9193237,
  "title": "TriSalus Life shares surge 29% on FDA device clearance",
  "url": "https://urgent.news/2026/09/22/trisalus-life-shares-surge-29-on-fda-device-clearance",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-22T20:39:15.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/trisalus-life-shares-surge-29-on-fda-device-clearance-93CH-4911658"
  },
  "original_language": "en",
  "account": null,
  "summary": "TriSalus Life Sciences shares surged by 29% following the company's announcement of receiving FDA 510(k) clearance for its new device, TriNav Advance. The device, a part of TriSalus' Pressure-Enabled Drug Delivery portfolio, expands the company's offerings by providing access to small, distal vessels. TriNav Advance can be used in two configurations: telescoping mode, which uses a compatible microcatheter for selective delivery to smaller, distal vessels, and high-flow mode, which functions like a standard TriNav device without an additional microcatheter. This addition to the company's device portfolio allows interventional radiologists to pair TriNav Advance with a compatible microcatheter of their choice, providing flexibility across a broader range of procedures and anatomies. The new device can be used in liver-directed therapy cases, with an indication that supports a broader range of embolization procedures beyond the liver.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}